FDA approves Pfizer and Myovant’s Endometriosis Drug Myfembree After Delay
After a delay, the United States Food and Drug Administration has approved the Pfizer and Myovant drug Myfembree. Myfembree is…
Medications
Will omicron-specific booster shots be more effective at combating COVID-19? 5 questions answered
On Aug. 31, 2022, the Food and Drug Administration authorized the use of updated COVID-19 booster shots that are specifically…
Depressive symptoms in perimenopause
Depressive symptoms are common in perimenopause. Women who may be more at risk include those with a family history or…
Breast cancer, aromatase inhibitors, and bone health
Aromatase inhibitors (AIs) are a first-line therapy for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. Because of the estrogen…
FDA Approves Brexafemme For Recurrent Yeast Infections
The Food and Drug Administration (FDA) has approved Brexafemme (ibrexafungerp) for a second indication for reduction in incidence of recurrent…